Healthcare focused scale Tullis Health Investors specializes exclusively in healthcare investing with funds focused on North America, indicating a deep domain inside the health tech, biotech, and medical services landscape which can be leveraged to target portfolio synergies, co-investment opportunities, or founder introductions.

Recent product launches Active rollout of AVISE CTD, Truvaga, TAC-STIM and gConcierge/gCDirect programs shows a growth mindset and willingness to expand into diagnostics, direct-to-consumer wellness, human performance collaboration, and physician prescriber networks—opportunities to cross-sell complementary healthcare solutions or form strategic partnerships.

Strategic partnerships Partnerships with Air Force Research Lab and Teijin for nVNS licensing highlight a track record in collaboration with large institutions and international licensing, suggesting potential collaborative deals, licensing opportunities, or channel partnerships with tech-enabled health solutions.

Expansion channels Launch of a U.S. e-commerce portal and online store for telehealth and gammaCore therapies points to omni-channel distribution capabilities and patient access improvements, presenting doors to SaaS-enabled telehealth platforms, digital health services, or direct-to-consumer channels for portfolio companies.

Financial footprint Annual revenue in the mid-range tens of millions and a multi-fund, North America–focused strategy imply appetite for scalable health businesses and potential co-investment rounds or LP engagements with matching growth-stage stakes and risk tolerance.